Similar articles

• Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.

  Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, Montinaro A, Di Sciascio G. Patti G, et al. J Am Coll Cardiol. 2007 Mar 27;49(12):1272-8. doi: 10.1016/j.jacc.2007.02.025. J Am Coll Cardiol. 2007. PMID: 17394957 Clinical Trial.
• The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes.

  Cuculi F, Radovanovic D, Eberli FR, Stauffer JC, Bertel O, Erne P; AMIS Plus Investigators. Cuculi F, et al. Cardiology. 2008;109(3):156-62. doi: 10.1159/000106676. Epub 2007 Aug 28. Cardiology. 2008. PMID: 17726316
• Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report.

  Cohen M, Diez J, Fry E, Rao SV, Ferguson JJ 3rd, Zidar J, Levine G, Shani J. Cohen M, et al. J Invasive Cardiol. 2006 Dec;18(12):617-39. J Invasive Cardiol. 2006. PMID: 17197714
• Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation.

  Waters DD, Ku I. Waters DD, et al. J Am Coll Cardiol. 2009 Oct 6;54(15):1434-7. doi: 10.1016/j.jacc.2009.05.062. J Am Coll Cardiol. 2009. PMID: 19796736
• Statins in acute coronary syndromes: do the guideline recommendations match the evidence?

  Morrissey RP, Diamond GA, Kaul S. Morrissey RP, et al. J Am Coll Cardiol. 2009 Oct 6;54(15):1425-33. doi: 10.1016/j.jacc.2009.04.093. J Am Coll Cardiol. 2009. PMID: 19796735 Review.